Literature DB >> 3409965

[3H]quaternised ICS 205-930 labels 5-HT3 receptor binding sites in rat brain.

K J Watling1, S Aspley, C J Swain, J Saunders.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3409965     DOI： 10.1016/0014-2999(88)90677-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  16 in total

Review 1.  5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis.

Authors:  M S Aapro
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

2.  Proceedings of the British Pharmacological Society. University of Manchester, 13-15 September 1989.

Authors: 
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

3.  [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion.

Authors:  D Hoyer; C Waeber; A Karpf; H Neijt; J M Palacios
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

4.  Species variations in 5-HT3 recognition sites labeled by 3H-quipazine in the central nervous system.

Authors:  S J Peroutka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

5.  Proceedings of the British Pharmacological Society. London, 19th-21st December. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

6.  [3H] GR67330, a very high affinity ligand for 5-HT3 receptors.

Authors:  G J Kilpatrick; A Butler; R M Hagan; B J Jones; M B Tyers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

7.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

8.  L-694,247: a potent 5-HT1D receptor agonist.

Authors:  M S Beer; J A Stanton; Y Bevan; A Heald; A J Reeve; L J Street; V G Matassa; R J Hargreaves; D N Middlemiss
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

9.  Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron.

Authors:  J L Muir; B J Everitt; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

10.  The effects of BRL 46470A, a novel 5-HT3 receptor antagonist, and lorazepam on psychometric performance and the EEG.

Authors:  C G Link; T J Leigh; J K Dennison
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.